ThermoGenesis Holdings Inc (THMO) - Financial and Strategic SWOT Analysis Review

September 2021 | 58 pages | ID: C299EC9FC1FEN
GlobalData

Abstracts

ThermoGenesis Holdings Inc (THMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ThermoGenesis Holdings Inc (ThermoGenesis), formerly Cesca Therapeutics Inc, researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the in the vascular and orthopedic markets. Its offers AutoXpress platform for automated clinical biobanking. The company is also developing CAR-TXpress platform for bio-manufacturing which find applications in immuno-oncology therapeutics. The company markets its products to patients, physician and partners in three target markets, namely, cellular therapeutics, medical/diagnostic device development and commercialization, and cell manufacturing and banking. ThermoGenesis is headquartered in Rancho Cordova, California, the US.

ThermoGenesis Holdings Inc Key Recent Developments

Sep 14,2021: ThermoGenesis awarded NIH SBIR phase I grant to develop key cell processing disposable for Quintessence automated manufacturing of gene-engineered autologous Cell (GEAC) therapies
Aug 12,2021: ThermoGenesis Holdings Announces Financial Results for the Second Quarter Ended June 30, 2021, and Provides Corporate Update
Aug 05,2021: ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2021 and Provide a Corporate Strategic Update
May 13,2021: ThermoGenesis Holdings Announces Financial Results for the First Quarter Ended March 31, 2021 and Provides Corporate Update
May 06,2021: ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2021 and Provide a Corporate Strategic Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

ThermoGenesis Holdings Inc - Key Facts
ThermoGenesis Holdings Inc - Key Employees
ThermoGenesis Holdings Inc - Key Employee Biographies
ThermoGenesis Holdings Inc - Major Products and Services
ThermoGenesis Holdings Inc - History
ThermoGenesis Holdings Inc - Company Statement
ThermoGenesis Holdings Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
ThermoGenesis Holdings Inc - Business Description
Product Category: Device Revenue
Performance
Product Category: Other
Performance
Product Category: Service Revenue
Performance
Product Category: Device
Overview
Performance
R&D Overview
ThermoGenesis Holdings Inc - Corporate Strategy
ThermoGenesis Holdings Inc - SWOT Analysis
SWOT Analysis - Overview
ThermoGenesis Holdings Inc - Strengths
ThermoGenesis Holdings Inc - Weaknesses
ThermoGenesis Holdings Inc - Opportunities
ThermoGenesis Holdings Inc - Threats
ThermoGenesis Holdings Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

ThermoGenesis Holdings Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
ThermoGenesis Holdings Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
ThermoGenesis Holdings Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 14, 2021: ThermoGenesis awarded NIH SBIR phase I grant to develop key cell processing disposable for Quintessence automated manufacturing of gene-engineered autologous Cell (GEAC) therapies
Aug 12, 2021: ThermoGenesis Holdings Announces Financial Results for the Second Quarter Ended June 30, 2021, and Provides Corporate Update
Aug 05, 2021: ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2021 and Provide a Corporate Strategic Update
May 13, 2021: ThermoGenesis Holdings Announces Financial Results for the First Quarter Ended March 31, 2021 and Provides Corporate Update
May 06, 2021: ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2021 and Provide a Corporate Strategic Update
Mar 17, 2021: ThermoGenesis holdings announces 2020 year end financial results and provides corporate update
Mar 10, 2021: ThermoGenesis Holdings to Announce Financial Results for the Fourth Quarter Ended December 31, 2020 and Provide a Corporate Strategic Update
Feb 17, 2021: ThermoGenesis Holdings begins a year of celebration of its 35th anniversary in the cell banking and cell therapy industry
Jan 07, 2021: Thermogenesis Holdings to Participate at the H.C. Wainwright BIOCONNECT 2021 Conference
Dec 18, 2020: ThermoGenesis Holdings: Management update

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

ThermoGenesis Holdings Inc, Key Facts
ThermoGenesis Holdings Inc, Key Employees
ThermoGenesis Holdings Inc, Key Employee Biographies
ThermoGenesis Holdings Inc, Major Products and Services
ThermoGenesis Holdings Inc, History
ThermoGenesis Holdings Inc, Other Locations
ThermoGenesis Holdings Inc, Subsidiaries
ThermoGenesis Holdings Inc, Key Competitors
ThermoGenesis Holdings Inc, Ratios based on current share price
ThermoGenesis Holdings Inc, Annual Ratios
ThermoGenesis Holdings Inc, Annual Ratios (Cont...1)
ThermoGenesis Holdings Inc, Annual Ratios (Cont...2)
ThermoGenesis Holdings Inc, Interim Ratios
ThermoGenesis Holdings Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
ThermoGenesis Holdings Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
ThermoGenesis Holdings Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

ThermoGenesis Holdings Inc, Performance Chart (2016 - 2020)
ThermoGenesis Holdings Inc, Ratio Charts
ThermoGenesis Holdings Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
ThermoGenesis Holdings Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021